BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12492493)

  • 1. Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.
    Sung SY; Chung LW
    Differentiation; 2002 Dec; 70(9-10):506-21. PubMed ID: 12492493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications.
    Chung LW
    Cancer; 2003 Feb; 97(3 Suppl):772-8. PubMed ID: 12548574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of stroma in carcinogenesis of the prostate.
    Cunha GR; Hayward SW; Wang YZ
    Differentiation; 2002 Dec; 70(9-10):473-85. PubMed ID: 12492490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
    Mueller MM; Fusenig NE
    Differentiation; 2002 Dec; 70(9-10):486-97. PubMed ID: 12492491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor microenvironment in prostate cancer bone metastasis.
    Morrissey C; Vessella RL
    J Cell Biochem; 2007 Jul; 101(4):873-86. PubMed ID: 17387734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of prostate cancer growth in bone microenvironments.
    Edlund M; Sung SY; Chung LW
    J Cell Biochem; 2004 Mar; 91(4):686-705. PubMed ID: 14991761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the stromal microenvironment in prostate cancer.
    Condon MS
    Semin Cancer Biol; 2005 Apr; 15(2):132-7. PubMed ID: 15652458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
    Loberg RD; Gayed BA; Olson KB; Pienta KJ
    J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells.
    Palumbo A; Ferreira LB; Reis de Souza PA; Oliveira FL; Pontes B; Viana NB; Machado DE; Palmero CY; Alves LM; Gimba ER; Nasciutti LE
    Cancer Lett; 2012 Aug; 321(1):55-64. PubMed ID: 22388175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
    Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
    Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
    Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
    Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.
    Olapade-Olaopa EO; MacKay EH; Taub NA; Sandhu DP; Terry TR; Habib FK
    Clin Cancer Res; 1999 Mar; 5(3):569-76. PubMed ID: 10100708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
    J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-stroma interactions: their role in the control of tumor cell invasion.
    Zigrino P; Löffek S; Mauch C
    Biochimie; 2005; 87(3-4):321-8. PubMed ID: 15781319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.